Condition: Glaucoma · Sponsor: University of Pennsylvania
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial (DECLARE) is a multi-center, outcome-masked, randomized clinical trial. The purpose of this study is to compare glaucoma drainage device implantation in the anterior chamber (front part of the eye) and sulcus (small space between iris and front chamber of the eye) in efforts to minimize cell loss in the eye.
This description comes directly from the study's public registry record.
Gui-shuang Ying, PhD · 215-615-1514 · gsying@pennmedicine.upenn.edu
Always discuss trial participation with your own doctor first.
| University of California San Francisco | San Francisco, California, United States | Recruiting |
| Diablo Eye Associates | Walnut Creek, California, United States | Recruiting |
| Bascom Palmer Eye Institute | Miami, Florida, United States | Recruiting |
| Wilmer Eye Institute, Johns Hopkins University | Baltimore, Maryland, United States | Recruiting |
| Massachusetts Eye and Ear | Boston, Massachusetts, United States | Recruiting |
| University of Buffalo/State University of New York | Buffalo, New York, United States | Recruiting |
| University of North Carolina at Chapel Hill | Chapel Hill, North Carolina, United States | Recruiting |
| Prism Eye Institute, University of Toronto | Toronto, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05924477